Plasminogen activator and receptor in osteoarthritis
- PMID: 7752114
Plasminogen activator and receptor in osteoarthritis
Abstract
Evidence indicates that breakdown of articular cartilage resulting in the loss of normal joint function is the distinctive feature of osteoarthritis. Degradation of cartilage extracellular matrix components involves the action of at least 2 classes of proteinases: serine proteinases and metalloproteinases. Receptors have been described on a wide range of cell lines for many such proteinases [urokinase-type plasminogen activator (u-PA), plasminogen/plasmin, collagenase], which subsequently activate each other on the solid phase of the cell surface, leading to cartilage destruction. We review the leading role of u-PA and its receptor (u-PAR) in cartilage degradation.
Similar articles
-
Antisense targeting of the urokinase receptor blocks urokinase-dependent proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro.Proc Assoc Am Physicians. 1998 Jul-Aug;110(4):340-50. Proc Assoc Am Physicians. 1998. PMID: 9686682
-
The urokinase receptor and cell migration.Semin Thromb Hemost. 1996;22(6):513-6. doi: 10.1055/s-2007-999053. Semin Thromb Hemost. 1996. PMID: 9122717 Review.
-
Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.Lab Invest. 1998 Sep;78(9):1109-19. Lab Invest. 1998. PMID: 9759655
-
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.Int J Oncol. 2005 Jul;27(1):223-35. Int J Oncol. 2005. PMID: 15942664
-
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S46-58. doi: 10.1097/01.blo.0000093845.72468.bd. Clin Orthop Relat Res. 2003. PMID: 14600592 Review.
Cited by
-
Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.Protein Sci. 1998 Oct;7(10):2118-26. doi: 10.1002/pro.5560071008. Protein Sci. 1998. PMID: 9792098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous